Literature DB >> 2224695

An anonymous seroprevalence survey of HIV infection among pregnant women in British Columbia and the Yukon Territory.

M T Schechter1, P J Ballem, N A Buskard, T N Le, M Thompson, S A Marion, M V O'Shaughnessy.   

Abstract

We performed an anonymous seroprevalence survey of human immunodeficiency virus (HIV) type 1 infection through HIV antibody testing of blood samples from 22,512 women aged 15 to 44 years receiving prenatal care in British Columbia and the Yukon Territory from Mar. 15 to Sept. 30, 1989. Of the samples six were confirmed to be HIV positive; this yielded a crude overall seroprevalence rate of 2.7 per 10,000 pregnant women (95% confidence interval [CI] 1.0 to 5.8). All of the positive samples were from women 20 to 29 years of age; four were from Vancouver, one was from Victoria, and one was from elsewhere. The highest seroprevalence rates were among women aged 15 to 29 years in Vancouver and Victoria (7.2 and 9.4 per 10,000 pregnant women respectively). Thus, 1 in 1300 pregnant women in that age group in the metropolitan areas of British Columbia was HIV positive. Application of seroprevalence rates to the total female population in British Columbia and the Yukon Territory revealed that as many as 401 women had HIV infection in 1989. Our estimates likely represent the minimum. As a subset of women of childbearing age pregnant women are likely at lowest risk of HIV infection, and so the true number of women 15 to 44 years of age with HIV infection is probably several times higher. Our study has provided a baseline assessment and will be repeated annually to analyse trends in HIV seroprevalence among pregnant women in British Columbia and the Yukon Territory.

Entities:  

Mesh:

Year:  1990        PMID: 2224695      PMCID: PMC1452880     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  8 in total

1.  A prospective study of male sexual contacts of men with AIDS-related conditions (ARC) or AIDS: HTLV-III antibody, clinical, and immune function status at induction.

Authors:  R A Coates; C L Soskolne; S E Read; M M Fanning; M M Klein; F A Shepherd; L Calzavara; J K Johnson; M V O'Shaughnessey
Journal:  Can J Public Health       Date:  1986 May-Jun

2.  Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases.

Authors:  T C Quinn; D Glasser; R O Cannon; D L Matuszak; R W Dunning; R L Kline; C H Campbell; E Israel; A S Fauci; E W Hook
Journal:  N Engl J Med       Date:  1988-01-28       Impact factor: 91.245

3.  HIV infection among Quebec women giving birth to live infants.

Authors:  C A Hankins; C Laberge; N Lapointe; M T Lai Tung; L Racine; M O'Shaughnessy
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

4.  Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women.

Authors:  S Landesman; H Minkoff; S Holman; S McCalla; O Sijin
Journal:  JAMA       Date:  1987-11-20       Impact factor: 56.272

5.  The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men.

Authors:  M T Schechter; W J Boyko; B Douglas; B Willoughby; A McLeod; M Maynard; K J Craib; M O'Shaughnessy
Journal:  CMAJ       Date:  1986-12-15       Impact factor: 8.262

6.  Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns.

Authors:  R Hoff; V P Berardi; B J Weiblen; L Mahoney-Trout; M L Mitchell; G F Grady
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

7.  Trial of anonymous versus confidential human immunodeficiency virus testing.

Authors:  L J Fehrs; D Fleming; L R Foster; R O McAlister; V Fox; S Modesitt; R Conrad
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

8.  Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic.

Authors:  H F Hull; C J Bettinger; M M Gallaher; N M Keller; J Wilson; G J Mertz
Journal:  JAMA       Date:  1988-08-19       Impact factor: 56.272

  8 in total
  12 in total

1.  Periodic health examination, 1992 update: 3. HIV antibody screening. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1992-09-15       Impact factor: 8.262

2.  The national AIDS strategy is a start, nothing more.

Authors:  J E Parker
Journal:  CMAJ       Date:  1991-03-01       Impact factor: 8.262

3.  Outpatient Management of HIV Infection: Providing adequate care to HIV patients.

Authors:  B Romanowski
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

4.  Human immunodeficiency virus as a sexually transmitted disease: Manitoba's HIV unlinked seroprevalence study.

Authors:  L Sekla; G Hammond; R Tate; W Stackiw; G Eibisch; S Shewchook
Journal:  Can J Infect Dis       Date:  1992-11

5.  Prevalence of HIV infection among pregnant women in Newfoundland.

Authors:  S Ratnam; K Hogan; C Hankins
Journal:  CMAJ       Date:  1996-04-01       Impact factor: 8.262

6.  Confronting HIV infection in prisons.

Authors:  C Hankins
Journal:  CMAJ       Date:  1994-09-15       Impact factor: 8.262

Review 7.  Changing epidemiology of AIDS.

Authors:  C A Donovan; E Stratton
Journal:  Can Fam Physician       Date:  1994-08       Impact factor: 3.275

8.  HIV infection among Quebec women giving birth to live infants.

Authors:  J E Parker
Journal:  CMAJ       Date:  1991-04-15       Impact factor: 8.262

Review 9.  Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.

Authors:  C B Nourse; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jan-Mar       Impact factor: 1.568

10.  Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.

Authors:  M Alary; J R Joly; R Parent; M Fauvel; M Dionne
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.